144 related articles for article (PubMed ID: 4569214)
1. Application of experimental keratoconjunctivitis shigellosa in chemotherapeutic evaluation of rifampicin to bacillary dysentery.
Osada Y; Nakajo M; Ogawa H
Jpn J Microbiol; 1972 Jul; 16(4):329-32. PubMed ID: 4569214
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic evaluation of rifampicin to experimental bacillary dysentery in cynomolgus monkeys.
Osada Y; Nakajo M; Inaba M; Une T; Ogawa H
Jpn J Microbiol; 1972 Jul; 16(4):275-85. PubMed ID: 4631612
[No Abstract] [Full Text] [Related]
3. A study on experimental keratoconjunctivitis shigellosa.
Okamoto M
Kitasato Arch Exp Med; 1980 Dec; 53(3-4):81-96. PubMed ID: 7035740
[No Abstract] [Full Text] [Related]
4. [The therapeutic efficacy of sodium nucleinate and monoribonucleotides based on keratoconjunctival test data].
Zemskov AM; Trutnev BD; Popova VP; Salomakhin GG; Dolzhanov AIa; Mikstaĭs IuIa
Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):71-4. PubMed ID: 8067149
[TBL] [Abstract][Full Text] [Related]
5. Application of cell culture in studying antibacterial activity of rifampicin to Shigella and enteropathogenic Escherichia coli.
Osada Y; Nakajo M; Une T; Ogawa H; Oshima Y
Jpn J Microbiol; 1972 Nov; 16(6):525-33. PubMed ID: 4571915
[No Abstract] [Full Text] [Related]
6. Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp.
Adamus G; Mulczyk M; Witkowska D; Romanowska E
Infect Immun; 1980 Nov; 30(2):321-4. PubMed ID: 7002794
[TBL] [Abstract][Full Text] [Related]
7. Acceptance of R factor by a Shigella sonnei strain from commensal Escherichia coli strains during dysentery.
Bohus J
J Hyg Epidemiol Microbiol Immunol; 1971; 15(2):225-6. PubMed ID: 4932306
[No Abstract] [Full Text] [Related]
8. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri].
Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK
Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775
[No Abstract] [Full Text] [Related]
9. On the taxonomy of Escherichia coli serotypes causing experimental keratoconjunctivitis shigellosa in guinea pigs.
Aldová E; Sourek J; Láznicková K
Arch Immunol Ther Exp (Warsz); 1968; 16(2):228-42. PubMed ID: 4969668
[No Abstract] [Full Text] [Related]
10. Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.
FRETER R
J Exp Med; 1956 Sep; 104(3):411-8. PubMed ID: 13357693
[TBL] [Abstract][Full Text] [Related]
11. [Experimental and clinical evaluation of rifampicin in bacillary dysentery].
Nakazawa S; Sato H
Nihon Densenbyo Gakkai Zasshi; 1969 Nov; 43(8):184-9. PubMed ID: 4983143
[No Abstract] [Full Text] [Related]
12. Rifampicin therapy in Gram-negative bacteraemia in infancy.
Naveh Y; Friedman A
Arch Dis Child; 1973 Dec; 48(12):967-9. PubMed ID: 4587814
[No Abstract] [Full Text] [Related]
13. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
[No Abstract] [Full Text] [Related]
14. [Antimicrobial activity of kalanchoe juice relative to dysentery bacteria].
Suptel' EA; Lapchik VF; Zagornaia NB; Shirobokov VP
Mikrobiol Zh (1978); 1980; 42(1):86-90. PubMed ID: 7366486
[No Abstract] [Full Text] [Related]
15. [Shigella keratoconjunctivitis reaction in guinea pig in the study of streptomycin and chlortetracycline effects].
MANOLOV DG; GESHEVA RL; TOSHKOV AS
Antibiotiki (Mosc); 1958; 3(5):72-5. PubMed ID: 24545106
[No Abstract] [Full Text] [Related]
16. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. II. HISTOLOGIC FINDINGS.
LIN FC; YANG TL; WU PF
Chin Med J; 1964 Jul; 83():463-9. PubMed ID: 14191219
[No Abstract] [Full Text] [Related]
17. [Experimental salmonellosis conjunctivitis and keratitis in guinea pigs].
Voĭno-Iasenetskiĭ MV; Ismailov EM; Dragunskaia EM; Ravdonikas LE
Zh Mikrobiol Epidemiol Immunobiol; 1977 Jul; (7):102-5. PubMed ID: 331788
[TBL] [Abstract][Full Text] [Related]
18. EXPERIMENTAL KERATOCONJUNCTIVITIS SHIGELLOSIS IN GUINEA PIGS. I. IMMUNE PHENOMENON AND ANTIBODY FORMATION.
LIN FC; YANG TL; YEH SH
Chin Med J; 1964 Jul; 83():454-62. PubMed ID: 14191218
[No Abstract] [Full Text] [Related]
19. [The pathogenic properties of streptomycin-dependent mutants of Sh. flexneri and its revertants].
Mikhaĭlov IF; Sergeev VV; Elkina SI
Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):10-4. PubMed ID: 5735219
[No Abstract] [Full Text] [Related]
20. Rifampicin therapy in shigellosis in infancy.
Naveh Y; Strahovsky P; Friedman A
Arch Dis Child; 1977 Dec; 52(12):960-1. PubMed ID: 343724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
